OpenAI-Backed Chai Discovery Reaches Unicorn Status with $130M Series B to Power AI-Driven Drug Discovery

Chai Discovery, a pioneering biotech firm with strategic backing from OpenAI, has announced a momentous $130 million Series B funding round, catapulting its valuation to an impressive $1.3 billion. This significant investment solidifies the company's position as